GlassScriptPhysician profile
Laura L Williams
NPI 1457318404
$2,599.27
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $740 · 2020: $234 · 2021: $306 · 2022: $631 · 2023: $602 · 2024: $87.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $689.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $497.96 | 2019-2024 | Keytruda |
| Eisai INC. | $237.81 | 2020-2023 | |
| Glaxosmithkline, LLC. | $191.97 | 2021-2023 | Zejula, Jemperli |
| Myriad Genetic Laboratories, INC. | $175.71 | 2021-2023 | Myrisk |
| Clovis Oncology, INC. | $174.36 | 2019-2022 | |
| Tesaro, INC. | $168.66 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $129.19 | 2019-2023 | Evusheld, Lynparza |
| Blueprint Medicines Corporation | $121.88 | 2022 | |
| Aspira Women'S Health INC | $107.81 | 2023-2024 | Ova1 |
| Ethicon US, LLC | $105.61 | 2019 | |
| Kyowa Kirin, INC. | $100.98 | 2019-2021 | |
| Seagen INC. | $82.01 | 2022-2023 | Tivdak |
| Amgen INC. | $72.10 | 2019 | |
| Hologic Sales and Service, LLC | $60.66 | 2021-2023 | Aptima |
| Mylan Institutional INC. | $58.22 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $38.91 | 2023 | Floseal |
| Stryker Corporation | $37.73 | 2023 | Spy-Phi System |
| Coopersurgical, INC. | $31.77 | 2019 | |
| Genentech USA, INC. | $31.57 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $29.11 | 2019 | |
| Immunogen, INC. | $29.09 | 2023 | Elahere |
| Coherus Oncology, INC. | $22.32 | 2020 | |
| Boston Scientific Corporation | $17.92 | 2024 | |
| Therapeuticsmd, INC. | $16.97 | 2020 | |
| Duchesnay USA Incorporated | $16.03 | 2019 | |
| Olympus America INC. | $14.89 | 2021 | |
| Foundation Medicine, INC. | $14.68 | 2020 | |
| Tactile Systems Technology INC | $13.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.